….. for Emergency Use Authorization of Novavax’ Recombinant Nanoparticle COVID-19 Vaccine – Novavax and Serum Institute of India file regulatory submissions to the Drugs Controller […]
The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, has granted approval for the first clinical trial with COVID-19 convalescent plasma (CAPSID) in Germany. The aim […]
As the COVID-19 pandemic sweeps across the globe, it is fast becoming clear that no one is exempt from its disruptive effects. IIASA researchers are […]
Melbourne researchers have mapped immune responses from one of Australia’s first novel coronavirus (COVID-19) patients, showing the body’s ability to fight the virus and recover […]
Copyright © 2021 | WordPress Theme by MH Themes
